Literature DB >> 10947965

Functional analysis of tumour necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL): cysteine-230 plays a critical role in the homotrimerization and biological activity of this novel tumoricidal cytokine.

D Trabzuni1, K S Famulski, M Ahmad.   

Abstract

We have determined that the mutation of the cysteine-230 residue to either glycine or serine in TRAIL (tumour necrosis factor-alpha-related apoptosis-inducing ligand) results in the formation of a structurally incompetent dimer and a consequent loss of apoptotic activity. Similarly, chemical modification of the thiol residues present in both reduced and Zn(2+)-depleted trimer converts TRAIL into an inactive dimer. We postulate that cysteine-230 plays a critical role in homotrimerization of this tumoricidal cytokine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947965      PMCID: PMC1221278     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.

Authors:  J Mongkolsapaya; J M Grimes; N Chen; X N Xu; D I Stuart; E Y Jones; G R Screaton
Journal:  Nat Struct Biol       Date:  1999-11

2.  Human ICE/CED-3 protease nomenclature.

Authors:  E S Alnemri; D J Livingston; D W Nicholson; G Salvesen; N A Thornberry; W W Wong; J Yuan
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

Review 3.  Programmed cell death in animal development.

Authors:  M D Jacobson; M Weil; M C Raff
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

4.  Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.

Authors:  S G Hymowitz; H W Christinger; G Fuh; M Ultsch; M O'Connell; R F Kelley; A Ashkenazi; A M de Vos
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

5.  Identification and characterization of a new member of the TNF family that induces apoptosis.

Authors:  S R Wiley; K Schooley; P J Smolak; W S Din; C P Huang; J K Nicholl; G R Sutherland; T D Smith; C Rauch; C A Smith
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

Review 6.  The killer and the executioner: how apoptosis controls malignancy.

Authors:  D R Green; S J Martin
Journal:  Curr Opin Immunol       Date:  1995-10       Impact factor: 7.486

Review 7.  Mechanisms and genes of cellular suicide.

Authors:  H Steller
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

8.  2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity.

Authors:  S S Cha; M S Kim; Y H Choi; B J Sung; N K Shin; H C Shin; Y C Sung; B H Oh
Journal:  Immunity       Date:  1999-08       Impact factor: 31.745

9.  Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.

Authors:  R M Pitti; S A Marsters; S Ruppert; C J Donahue; A Moore; A Ashkenazi
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

Review 10.  Apoptosis in the pathogenesis and treatment of disease.

Authors:  C B Thompson
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

View more
  8 in total

Review 1.  Life and death by death receptors.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

Review 2.  The TRAIL to viral pathogenesis: the good, the bad and the ugly.

Authors:  Nathan Cummins; Andrew Badley
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

3.  Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving caspase-8 activation.

Authors:  Raïd Kassis; Florence Larrous; Jérôme Estaquier; Hervé Bourhy
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 4.  The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis.

Authors:  Jason P Twohig; Simone M Cuff; Audrey A Yong; Eddie C Y Wang
Journal:  Rev Neurosci       Date:  2011-08-24       Impact factor: 4.353

5.  Targeted delivery of tumor necrosis factor-related apoptosis-inducing ligand to keratinocytes with a pemphigus mAb.

Authors:  Michiyoshi Kouno; Chenyan Lin; Norman M Schechter; Don Siegel; Xiaoping Yang; John T Seykora; John R Stanley
Journal:  J Invest Dermatol       Date:  2013-02-25       Impact factor: 8.551

6.  Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy.

Authors:  Fan Qiu; Minjin Hu; Bo Tang; Xiufeng Liu; Hongqin Zhuang; Jie Yang; Zi-Chun Hua
Journal:  Sci Rep       Date:  2013-12-20       Impact factor: 4.379

7.  Expression of TNF-related apoptosis-inducing ligand (TRAIL) in keratinocytes mediates apoptotic cell death in allogenic T cells.

Authors:  Kerstin Reimers; Christine Radtke; Claudia Y Choi; Christina Allmeling; Susanne Kall; Paul Kiefer; Thomas Muehlberger; Peter M Vogt
Journal:  Ann Surg Innov Res       Date:  2009-11-19

Review 8.  TRAIL signals, extracellular matrix and vessel remodelling.

Authors:  Manisha S Patil; Siân P Cartland; Mary M Kavurma
Journal:  Vasc Biol       Date:  2020-06-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.